ClinicalTrials.gg
RecruitingNCT06749080Updated Mar 7, 2025

ASSIST 2.0: a Reablement Program for Healthy Ageing

An interventional study of Assist Reablement (including education and mentoring) in Reablement and Frailty, sponsored by Aileen Bergström. Recruiting at 2 sites in Sweden. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-07.

Sponsored by Aileen Bergström · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Frailty with a site in Sweden — 11 open to participants now, 13 under way, none of them phase 3. Frailty · Sweden.

Planned enrollment
14th of 14
100 · median 216
Started
2025
with 3 others
No phase
14 of 32
7 open now
Primary completion
2027-09
later than 7 of 12 live
Registered
29th of 32
by date
Lead sponsor
1 of 32
Aileen Bergström

Among the 32 studies in Frailty with a site in Sweden, this one is the 14th largest by planned enrollment of the 14 interventional ones that give a count, is one of 4 that started in 2025, is one of 14 with no phase, reaches primary completion later than 7 of the 12 other live ones, and was the 29th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

11 of the 32 studies in Frailty with a site in Sweden are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Frailty with a site in Sweden, or all of them as a file.
02

Study summary

The goal of this study is to continue to develop, implement, and evaluate a unique reablement service, ASSIST 2.0. The project will determine the differences in the reablement service (ASSIST 2.0) compared to regular home care in terms of older adults' performance in daily activities, self-efficacy, perceived health, quality of life, frailty and perceived person-centered approach.

The research question is: Can older adults receiving ASSIST 2.0 improve their performance and satisfaction in daily life activities, experience a higher level of self-efficacy, perceived health, quality of life and a person-centered approach?

The ASSIST project involves older adults receiving home care, home care assistants, occupational and physical therapists. ASSIST 2.0 reablement consists of the following components:

  • an intervention aimed at older adults to help them perform daily activities they need and want to do. This will be achieved through optimal support from home care staff,
  • an on-line education provided by the researchers for all staff in the art and science of reablement,
  • training and support through mentorship and coaching provided by occupational and physical therapists for home care staff to ensure the proper delivery of reablement.
03

Conditions studied

  • Reablement
  • Frailty

Browse trials for

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Homecare has been granted
  • The person can describe an ordinary day and what they have problems with doing
  • 65 years of age or over

Exclusion criteria

Exclusion criteria:

  • The person has palliative care
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Intervention group - ASSIST intervention groups Uppsala/Stockholm

    All staff in the intervention group will recieve an on-line reablement education. The occupational and physcial therapist in the intervention group will provide mentoring including reflection for the homecare staff. Together the team will focus on the older persons everyday occuations and deliver reablement to the older persons.

    Behavioral: Assist Reablement (including education and mentoring)

  • No intervention
    Control group Uppsala/Stockholm

    The older person will recieve home care as usual without a reablement education or support from occupational or physical therapists.

Interventions

  • BehavioralAssist Reablement (including education and mentoring)

    Reablement on-line education will be standard and mandatory for both intervention groups. Mentoring will be formed according to the pre-requisites at the site.

06

What researchers measure

Primary outcomes

  1. The improvement of performance and/or satisfaction in prioritized everyday activities after the end of the reablement intervention, 6 and 12 months post baseline.

    The Canadian Occupational Performance Measure (COPM) will be used. The COPM measures the level of self-assessed performanace and satisfaction of up to five prioritized everyday activities that the person needs, wants or is expected to do, but percieves difficulties doing them. The person rates, for each everyday activity, on a scale of 1 to 10 the prioritisation, the performance and the satisfaction of the activity. For the prioritisation 10 represents very important, one not important). For the performance scale, 10 represents the person does the activity extremely well, and one represents can not do the activity at all. For the satisfaction scale, 10 represents being extremely satisfied and and one not satisfied at all. An increase in two points or more from base-line to follow-up is a positive clinically significant difference.

    Time frame: Measurements will be at baseline, two weeks post base line, at the end of the intervention (6-12 weeks post baseline), 6 and 12 months post baseline.

07

Study locations

1 of 2 sites recruiting
  • Karolinska Institutet
    Huddinge, 181 83, Sweden
    Active, not recruiting

    Not enrolling at this site.

  • Uppsala Kommun
    Uppsala, 753 75, Sweden
    Recruiting
08

References and documents

Publications

  • Assander S, Bergstrom A, Eriksson C, Meijer S, Guidetti S. ASSIST: a reablement program for older adults in Sweden - a feasibility study. BMC Geriatr. 2022 Jul 26;22(1):618. doi: 10.1186/s12877-022-03185-2. PubMed 35879678 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Sep 2027, 31 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 31 months is above that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2024
First posted
Dec 27, 2024
StartActual
Feb 3, 2025
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2028
Last update
Mar 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06749080
Lead sponsor
Aileen Bergström
Collaborators
Forte
Responsible party
Aileen Bergström (PhD, Ass. Lecturer, Karolinska Institutet) — Sponsor-investigator
First posted
Dec 27, 2024
Start date
Feb 3, 2025
Primary completion
Sep 2027 (estimated)
Completion
Sep 2028 (estimated)
Last update
Mar 7, 2025

Study contacts

Aileen L Bergström, PhD
Contact
aileen.bergstrom@ki.se
+4673 7490139
Susanne Assander, PhD
Contact
susanne.assander@uu.se
Susanne Guidetti, PhD, Professor
study director · Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion